Target intelligence / Profile preview

Rap guanine nucleotide exchange factor 3 (RAPGEF3)

Target
RAPGEF3
Molecular classification
Guanine nucleotide exchange factor (GEF), Intracellular cAMP sensor, Enzyme (Signal transduction protein)
01

Overview

Rap guanine nucleotide exchange factor 3 (RAPGEF3), also known as EPAC1, is a cytosolic enzyme that acts as a guanine nucleotide exchange factor specifically for the small GTPases Rap1 and Rap2, becoming activated by direct binding of cyclic adenosine monophosphate (cAMP). RAPGEF3 functions as a major cAMP sensor in human cells, mediating cAMP-induced, protein kinase A-independent signaling pathways. It plays critical roles in regulating actin cytoskeletal dynamics, endothelial barrier function, cellular adhesion, proliferation, stress responses, and other processes. RAPGEF3 is implicated in various pathological states, including cardiovascular disease, cancer, and neuroinflammation, and is considered a potential therapeutic target for related conditions. Small molecules that selectively modulate EPAC1 activity are being investigated for therapeutic intervention.

Other names
EPAC1Exchange protein directly activated by cAMP 1cAMP-GEFIexchange factor directly activated by cAMP 1cAMP-regulated guanine nucleotide exchange factor ICGEF1bcm910RAP1 guanine-nucleotide-exchange factor directly activated by cAMPHSU792759330170P05Rik
02

Mechanism of action

Direct modulation of intracellular cAMP signaling by allosterically activating or inhibiting RAPGEF3, leading to downstream regulation of Rap GTPase activity and integrin/cytoskeletal effects

03

Biological functions

cAMP signal transductionActivation of Rap1 and Rap2 small GTPasesRegulation of endothelial barrier functionActin cytoskeleton rearrangement at cell junctionsCellular response to stressRegulation of cell adhesion and proliferation
04

Disease associations

Cardiovascular disease (e.g., heart failure)CancerChronic painInfectious diseaseNicotine dependenceCarney complex variantThrombocytopenia
05

Safety considerations

Potential for off-target cAMP pathway effectsBroad physiological roles present challenges for selective modulation
06

Interacting drugs

Small-molecule EPAC1 modulators (e.g., ESI-09, CE3F4)

1 more in the full profile.

07

Biomarkers

Circulating RAPGEF3 protein (biomarker for congestive heart failure)

Beyond the preview

Go deeper on Rap guanine nucleotide exchange factor 3 (RAPGEF3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rap guanine nucleotide exchange factor 3 (RAPGEF3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call